Long‐term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first‐line therapy: A retrospective analysis from two institutions-Reference-Cited by-同舟云学术

Long‐term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first‐line therapy: A retrospective analysis from two institutions

Published:2019-12-22 Issue:3 Volume:104 Page:198-206
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Mercadal Santiago¹^ORCID,Sancho Juan‐Manuel²^ORCID,Climent Fina³,Tapia Gustavo⁴,Pomares Helena¹,Carro Itziar¹,Sorigué Marc²,Pané Maria³,Domingo‐Doménech Eva¹,Encuentra Maite¹,Aguilera Carmen¹,Oliveira Ana Carla¹,Andrade Marcio¹,Fernández de Sevilla Alberto¹,Ribera Josep Maria²,González‐Barca Eva¹,Sureda Anna¹

Affiliation:

1. Department of Hematology Catalan Institute of Oncology Hospital Duran i Reynals IDIBELL Universitat de Barcelona L’Hospitalet de Llobregat Spain

2. Department of Hematology Catalan Institute of Oncology Hospital Germans Trias i Pujol Institut Josep Carreras Badalona Spain

3. Department of Pathology Hospital de Bellvitge L’Hospitalet de Llobregat Spain

4. Department of Pathology Hospital Germans Trias i Pujol Universitat Autònoma de Barcelona Badalona Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13359

Reference19 articles.

1. Patients with grade 3 follicular lymphoma have prolonged relapse‐free survival following anthracycline‐based chemotherapy: the Nebraska Lymphoma Study Group Experience. Annals;Ganti AK;Oncology,2006

2. FOLLICULAR LYMPHOMAS:

3. Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy

4. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL

5. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose chemotherapy with transplantation of autologous hematopoietic stem cells in the first line of follicular lymphoma therapy;Russian journal of hematology and transfusiology;2023-11-16

2. HIGH- DOSE CHEMOTHERAPY WITH TRANSPLANTATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS IN THE FIRST LINE OF FOLLICULAR LYMPHOMA THERAPY;GEMATOL TRANSFUZIOL;2023

3. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis;Annals of Hematology;2022-08-27

4. Follicular lymphoma: is there an optimal way to define risk?;Hematology;2021-12-10